The Latest Breaking News on Pharma

Crispr is facing its make-or-break moment and, experts say, a pivotal decision in December could spark more than just beleaguered CRSP stock.

While pharmacies say they can still fill most prescriptions for amoxicillin, the most-prescribed drug in the country, the shortage could worsen when the viral season hits this winter, experts say.

Neurocrine is Tuesday's IBD Stock Of The Day. After it unveiled promising results for a genetic disease drug, NBIX stock is on the rise.

An OTC birth control pill will help ensure more people can access the contraception they need without barriers

Narcan is now available in drug stores without a prescription. The nasal spray can save a life by stopping an opioid overdose. But will people pay the price and ask for it by name?

Morphic stock plummeted Monday after the company's ulcerative colitis drug underperformed a rival. MORF stock has lost 55% over two days.

Pharmacists will be able to prescribe medications and administer more vaccines under a pilot program being expanded throughout Queensland.

Draft patent rules threaten pre-grant opposition, a key public health safeguard. Big pharma seeks to remove essential safeguards from India’s patent laws, creating needless hurdles in pre-grant opposition. Draft rules introduce variable fees, power to determine maintainability of representation by individuals/groups. This threatens access to quality-assured, affordable generics & extends…

With the rising aging population and the emergence of new diseases, the biotech industry appears poised for steady growth. Therefore, three quality biotech stocks, Vanda Pharmaceuticals (VNDA), Organogenesis Holdings (ORGO), and Exelixis (EXEL), could be better catches than Bionano Genomics (BNGO). Read on….